Advertisement

Biochemistry (Moscow)

, Volume 81, Issue 11, pp 1237–1239 | Cite as

Molecular and cellular mechanisms of inflammation

  • D. V. KuprashEmail author
  • S. A. Nedospasov
Molecular and Cellular Mechanisms of Inflammation (Special Issue) Guest Editors S. A. Nedospasov and D. V. Kuprash
  • 147 Downloads

Abstract

Inflammation is one of the most fundamental and pronounced protective reactions of the organism. From ancient times to the present day, complex and diverse patterns of inflammation development and their role in various diseases have attracted attention of investigators. This issue of Biokhimiya/Biochemistry (Moscow) includes experimental studies and reviews dedicated to various aspects of this important and interesting problem.

Keywords

signs of inflammation infection tissue damage phagocytosis innate immunity inflammatory mediators polymorphism 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Spector, W. G., and Willoughby, D. A. (1964) Vasoactive amines in acute inflammation, Ann. N. Y. Acad. Sci., 116, 839–846.CrossRefPubMedGoogle Scholar
  2. 2.
    Menkin, V., and Warner, C. R. (1937) Studies on inflammation. XIII. Carbohydrate metabolism, local acidosis, and the cytological picture in inflammation, Am. J. Pathol., 13, 25–44.1.Google Scholar
  3. 3.
    Rocha e Silva, M. (1994) A brief survey of the history of inflammation. 1978, Agents Actions, 43, 86–90.CrossRefPubMedGoogle Scholar
  4. 4.
    Turk, J. L. (1994) Inflammation: John Hunter’s “A treatise on the blood, inflammation and gun-shot wounds”, Int. J. Exp. Pathol., 75, 385–395.PubMedGoogle Scholar
  5. 5.
    Medzhitov, R. (2010) Inflammation 2010: new adventures of an old flame, Cell, 140, 771–776.CrossRefPubMedGoogle Scholar
  6. 6.
    Molenaar, J. C. (2003) From the library of the Netherlands Journal of Medicine. Rudolf Virchow: die Cellularpathologie in ihrer Begrundung auf physiologische und pathologische Gewebelehre; 1858, Ned. Tijdschr. Geneeskd., 147, 2236–2244.PubMedGoogle Scholar
  7. 7.
    Gordon, S. (2008) Elie Metchnikoff: father of natural immunity, Eur. J. Immunol., 38, 3257–3264.CrossRefPubMedGoogle Scholar
  8. 8.
    Shacter, E., and Weitzman, S. A. (2002) Chronic inflammation and cancer, Oncology, 16, 217–226, 229; discussion 230-212.PubMedGoogle Scholar
  9. 9.
    Hotamisligil, G. S. (2006) Inflammation and metabolic disorders, Nature, 444, 860–867.CrossRefPubMedGoogle Scholar
  10. 10.
    Laveti, D., Kumar, M., Hemalatha, R., Sistla, R., Naidu, V. G., Talla, V., Verma, V., Kaur, N., and Nagpal, R. (2013) Anti-inflammatory treatments for chronic diseases: a review, Inflamm. Allergy Drug Targets, 12, 349–361.CrossRefPubMedGoogle Scholar
  11. 11.
    Gabrilovich, D. I., and Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system, Nat. Rev. Immunol., 9, 162–174.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Spits, H., and Cupedo, T. (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function, Annu. Rev. Immunol., 30, 647–675.CrossRefGoogle Scholar
  13. 13.
    Luster, A. D. (1998) Chemokines–chemotactic cytokines that mediate inflammation, N. Engl. J. Med., 338, 436445.Google Scholar
  14. 14.
    Libby, P., Ridker, P. M., and Maseri, A. (2002) Inflammation and atherosclerosis, Circulation, 105, 11351143.Google Scholar
  15. 15.
    Kawai, T., and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors, Nat. Immunol., 11, 373–384.CrossRefPubMedGoogle Scholar
  16. 16.
    Wallin, R. P., Lundqvist, A., More, S. H., Von Bonin, A., Kiessling, R., and Ljunggren, H. G. (2002) Heat-shock proteins as activators of the innate immune system, Trends Immunol., 23, 130–135.CrossRefPubMedGoogle Scholar
  17. 17.
    Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., and Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, 440, 237–241.CrossRefPubMedGoogle Scholar
  18. 18.
    Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., and Tschopp, J. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica, Science, 320, 674–677.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., and Flavell, R. A. (2008) Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants, Nature, 453, 1122–1126.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Stranger, B. E., Forrest, M. S., Dunning, M., Ingle, C. E., Beazley, C., Thorne, N., Redon, R., Bird, C. P., De Grassi, A., Lee, C., Tyler-Smith, C., Carter, N., Scherer, S. W., Tavare, S., Deloukas, P., Hurles, M. E., and Dermitzakis, E. T. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes, Science, 315, 848–853.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., and Tanaka, T. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction, Nat. Genet., 32, 650–654.CrossRefPubMedGoogle Scholar
  22. 22.
    Kubaszek, A., Pihlajamaki, J., Komarovski, V., Lindi, V., Lindstrom, J., Eriksson, J., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Tuomilehto, J., Uusitupa, M., Laakso, M., and Finnish Diabetes Prevention Study (2003) Promoter polymorphisms of the TNF-a (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the finnish diabetes prevention study, Diabetes, 52, 1872–1876.CrossRefPubMedGoogle Scholar
  23. 23.
    Ridker, P. M., Hennekens, C. H., Buring, J. E., and Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women, N. Engl. J. Med., 342, 836–843.CrossRefPubMedGoogle Scholar
  24. 24.
    Barnes, P. J., and Adcock, I. M. (2009) Glucocorticoid resistance in inflammatory diseases, Lancet, 373, 19051917.CrossRefGoogle Scholar
  25. 25.
    Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., and Hennekens, C. H. (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N. Engl. J. Med., 336, 973–979.PubMedGoogle Scholar
  26. 26.
    Shoelson, S. E., Lee, J., and Goldfine, A. B. (2006) Inflammation and insulin resistance, J. Clin. Invest., 116, 1793–1801.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., and Gage, F. H. (2010) Mechanisms underlying inflammation in neurodegeneration, Cell, 140, 918–934.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2016

Authors and Affiliations

  1. 1.Engelhardt Institute of Molecular BiologyRussian Academy of SciencesMoscowRussia
  2. 2.Lomonosov Moscow State UniversityMoscowRussia

Personalised recommendations